Author: OurCrowd

[Alpha Tau in Alpha Tau] ATM submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT for Recurrent Head & Neck Cancer

Nov 20, 2023 |

Jerusalem, November 20, 2023 — Alpha Tau Medical Ltd. (“Alpha Tau”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and HekaBio K.K. (“HekaBio”) a Japan-based healthcare investment, development and commercialization platform which is partnered with Alpha Tau, announced today that Japan’s Pharmaceuticals and Medical Devices Agency (“PMDA”) has accepted Alpha Tau’s submission requesting shonin pre-market approval of Alpha DaRT in patients with recurrent head & neck cancer, following multiple pre-submission consultation meetings with the PMDA per common practice in Japan. This submission is based upon Alpha DaRT’s clinical trial results in Japan which exceeded the target endpoints for safety and efficacy in patients with recurrent head and neck cancer. Read...

Read More

[BriefCam in Security Systems News] Briefcam introduces optimized, bundled hardware & software

Nov 20, 2023 |

BOSTON – Video analytics provider BriefCam announced the North American release of their bundled software and hardware offerings. The BriefCam Compact and BriefCam Grow hardware and software bundles have been packaged for easy implementation by BriefCam’s extensive channel partner network and optimized for BriefCam Insights video analytics software according to the company. Read more...

Read More